»
Antikörper
»
anti-SET Domain, Bifurcated 2 (SETDB2) Antikörper
SET Domain, Bifurcated 2 (SETDB2) Antikörper
| Antigen |
|
| Synonyme |
CLLD8, CLLL8, KMT1F, C13orf4, DKFZp586I0123, DKFZp761J1217, Clld8, Gm293 |
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
|
| Produktnummer |
ABIN184878 |
| Menge |
100 ug |
| Preis |
286,00 € Zzgl. Versandkosten €40,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 Werktagen |
|
Weitere Bezeichnung
|
CLLD8 / SETDB2
|
|
Gen-ID
|
83852
|
|
Immunogen
|
GEKNGDAKTFWME-C
|
|
Format
|
Affinity-purified
|
|
Beschreibung
|
All names and symbols: SETDB2, CLLD8, SET domain, bifurcated 2, CLLL8 protein. Official Symbol: SETDB2. RefSeq number(s): NP_114121.1
|
|
Spezifität
|
Human
|
|
Applikationshinweise
|
Peptide ELISA: antibody detection limit dilution 1:1,000. Western Blot: Approx 80kDa band observed in human heart lysates (calculated MW of 81.9kDa according to NP_114121.1). Recommended concentration: 0.3-1µg/ml.
|
|
Reinigung
|
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
|
|
Buffer
|
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
|
|
Lagerung
|
Aliquot and store at -20°C. Minimize freezing and thawing.
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
|
Publikationen
|
Mabuchi, Fujii, Calin et al.: "Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia." in: Cancer research, Vol. 61, Issue 7, pp. 2870-7, 2001 (PubMed).
|
Alternativen zu Antigen "SET Domain, Bifurcated 2 (SETDB2)", Typ "Antikörper" finden
|
Wirte
|
Maus (6), Kaninchen (6), Ziege (5)
|
|
Reaktivitäten
|
Human (15), Hund (2), Maus (2), Schwein (2)
|
|
Applikationen
|
Western Blot (WB) (12), Enzyme Immunoassay (EIA) (10), Immunfluoreszenz (IF) (2), Dot Blot (Dot) (1), ELISA (1), Immunpräzipitation (IP) (1)
|
|
Epitope
|
N-Term (1)
|